Schedule 13G ownership disclosure

Nurix Therapeutics Inc

COMMON STOCK · CUSIP: 67080M103

Event date: 2024-11-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • FMR LLC

    Shares: 10,306,351.07 · Class: 14.5%

  • Abigail P. Johnson

    Shares: 10,306,351.07 · Class: 14.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-24-002980
Form type
SCHEDULE 13G
Filer
FMR LLC
CIK
CIK 315066
Filed
Dec 06, 2024
Reporting period
Nov 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub